Emergent BioSolutions (NYSE:EBS – Get Free Report) posted its quarterly earnings results on Wednesday. The biopharmaceutical company reported $0.59 earnings per share for the quarter, beating the consensus estimate of ($3.65) by $4.24, Zacks reports. Emergent BioSolutions had a negative net margin of 47.68% and a negative return on equity of 17.91%. The firm had […]
Nearly 9 in 10 Americans surveyed agree opioid overdoses are a concern for teenagers and college students; parents in the survey want life-saving treatment.
Emergent BioSolutions Inc. (NYSE:EBS – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Traders purchased 3,153 put options on the stock. This is an increase of 344% compared to the typical daily volume of 710 put options. Emergent BioSolutions Stock Performance Shares of NYSE:EBS traded up $0.03 on Wednesday, […]
First Quarter 2024 Total Revenues of $300.4 million, above the prior guidance rangeFirst Quarter 2024 Net Income of $9.0 million and Adjusted EBITDA of.